Mesentech
Developer of prostaglandin prodrugs designed to support musculoskeletal regeneration. The company's drug conjugates target mesenchymal stem cells with a potent sub-nano-molar prostaglandin mimetic tha...
Valuation
$0
Share Price
N/A
Total Raised
$27.5M
Last Round
N/A